Ms. Carolyn Bonner reports

MEDICUS PHARMA LTD. ANNOUNCES LISTING ON FRANKFURT STOCK EXCHANGE

Medicus Pharma Ltd. has listed its common shares on the Frankfurt Stock Exchange under identification number (WKN) A3ES6P and ticker symbol N46. The company's common shares continue to be listed on the TSX Venture Exchange under the symbol MDCX.

About Medicus Pharma Ltd:

Medicus Pharma is a clinical-stage, multistrategy holding company focused on investing in and accelerating novel life sciences and biotechnology companies through FDA-approved (U.S. Food and Drug Administration) clinical trials.

Through its diverse experience and extensive industry network, the company is building Medicus into a leading pharmaceutical holding company, committed to delivering better treatment outcomes and alleviate pain and suffering. Utilizing a thesis-driven collaborative process, the company identifies, acquires and advances relatively derisked clinical-stage assets through clinical development and commercialization.

Skinject Inc., a wholly owned subsidiary of Medicus Pharma, is a development-stage life sciences company focused on commercializing novel, non-invasive treatment for basal cell and squamous cell skin cancer using patented dissolvable microneedle patch to deliver chemotherapeutic agent to eradicate tumour cells. The company currently has an FDA-approved phase 2 trial actively recruiting patients.

We seek Safe Harbor.